| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |